Obecabatagene autoleucel CAR-T approved by NICE: What you need to know
Today (Tuesday 25th November 2025) obecabtagene autoleucel (obe-cel) has been approved for use on NHS in most of the UK. It is a type of CAR-T cell therapy for certain adults with B cell acute lymphoblastic leukaemia (ALL). The brand name for obecel is Aucatzyl. ...